Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

82.94 -0.12 (-0.14%)
Official Closing Price Updated: 7:00 PM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
3 Medtech Companies with Higher Future Share Prices
The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond. 
Via MarketBeat
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday
The compay might soon be swallowed by a larger rival. 
Via The Motley Fool
Shockwave Rockets As Boston Scientific Reportedly Mulls A Takeover
The deal would help bolster Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Diversified Abbott Laboratories Could Reverse And Move Higher
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline. 
Via MarketBeat
Exposures COVID-19
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
NVIDIA, Boston Scientific And This Technology Stock Insiders Are Selling
The Nasdaq Composite closed higher by over 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Analyst Expectations for Boston Scientific's Future
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
8 Analysts Have This to Say About Boston Scientific
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Records 52-Week High Wednesday Morning
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
Why Boston Scientific Shares Are Trading Higher Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Preview Of Boston Scientific's Earnings
Via Benzinga
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
Thermo Fisher provided a bullish outlook, while Boston Scientific's profit view was short. 
Via Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one. 
Via MarketBeat
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem. 
Via Benzinga
How Doug Godshall Ignited The Spark At Shockwave
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula. 
Via Investor's Business Daily
Is Medtronic Stock Ready to Revive?
The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out. 
Via MarketBeat
Topics Economy
Exposures Interest Rates Supply Chain
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.